BeOne Medicines (ONC) Total Non-Current Liabilities (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Total Non-Current Liabilities data on file, last reported at $2.0 billion in Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 453.09% year-over-year to $2.0 billion in Q1 2026; TTM through Mar 2026 was $2.0 billion, a 453.09% increase from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 434.67% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $2.0 billion, down from $2.0 billion in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for ONC reached as high as $2.0 billion in Q4 2025 and fell as low as $318.1 million in Q2 2025.
• Historically, Total Non-Current Liabilities has averaged $705.7 million across 5 years, with a median of $525.1 million in 2023.
• Across the five-year window, Total Non-Current Liabilities tumbled 34.35% in 2022 and soared 453.09% in 2026, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $527.4 million in 2022, then declined by 13.19% to $457.8 million in 2023, then dropped by 18.36% to $373.8 million in 2024, then jumped by 434.67% to $2.0 billion in 2025, then dropped by 0.84% to $2.0 billion in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.1 billion in Q3 2025.